Skip to content

GMP Guideline

Trusted GMP guidance written for real-world professionals

Tag: pharmaceutical manufacturing

  • Home
  • pharmaceutical manufacturing
  • Page 12
Quality Assurance under GMP

Consequences of Product Disposition Without Investigation

Consequences of Product Disposition Without Investigation Implications of Uninvestigated Product Disposal in GMP Environments In…
Validation and Qualification

Inspection Focus on Computer System Validation Programs

Inspection Focus on Computer System Validation Programs Essential Insights on Computer System Validation Programs for…
Validation and Qualification

CSV Protocols Not Reflecting Intended System Use

CSV Protocols Not Reflecting Intended System Use Computer System Validation Protocols Misaligned with System Utilization…
Quality Assurance under GMP

Requirements for Complete Documentation Prior to Release Approval

Requirements for Complete Documentation Prior to Release Approval Key Documentation Requirements for Approval of Product…
Validation and Qualification

Inadequate Access Control in GMP Computer Systems

Inadequate Access Control in GMP Computer Systems Challenges of Inadequate Access Control in GMP Computer…
Quality Assurance under GMP

Impact of Delayed Product Release on GMP Compliance

Impact of Delayed Product Release on GMP Compliance The Consequences of Postponed Product Release on…
Validation and Qualification

Failure to Review Audit Trails in Validated Systems

Failure to Review Audit Trails in Validated Systems Understanding the Importance of Audit Trail Review…
Quality Assurance under GMP

Risks Associated with Incorrect Product Disposition Decisions

Risks Associated with Incorrect Product Disposition Decisions Potential Risks from Erroneous Product Disposition Choices in…
Quality Assurance under GMP

Risks Associated with Incorrect Product Disposition Decisions

Risks Associated with Incorrect Product Disposition Decisions Understanding the Risks of Erroneous Product Disposition Decisions…
Quality Assurance under GMP

Regulatory Considerations for Batch Release with Open Deviations

Regulatory Considerations for Batch Release with Open Deviations Introduction to Batch Release with Open Deviations…

Posts pagination

Previous 1 … 11 12 13 … 76 Next

Recent Posts

  • Failure to Maintain Standard Usage Logs
  • Regulatory Risks from Poor Document Traceability
  • Regulatory Risks from Inconsistent Standard Usage
  • Gaps in SOP Review and Approval Processes
  • Audit Observations Related to Standard Handling

Categories

  • Documentation and Data Integrity
  • Global GMP Guidelines
  • GMP Audits and Inspections
  • GMP Basics
  • GMP by Industry
  • Pharmaceutical GMP
  • Quality Assurance under GMP
  • Quality Control under GMP
  • SOPs
  • Training and Careers
  • Validation and Qualification
Copyright © 2026 GMP Guideline Theme: Timely News By Artify Themes.